ghk-cu study news 2025 The beauty industry welcomes a flood of new peptide products Wellness peptide craze: why people

This structural modification was rationally designed to optimize binding affinity to NNMT while dramatically improving membrane permeability a critical limitation of the parent 1-MQ molecule

A formal Phase 2 trial was completed in 2009, but over 15 years later, the results have never been published, another major red flag suggesting it failed to prove effective or safe

For laboratory research use only

doi:10.1126/science.1384126 38

There have been small phase one and phase two trials on rectal BPC-157 enemas, which showed no adverse effects, but the data is limited, and most of it comes from one research group, with some replication by Chinese groups 6m1s